CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis. / Ridiandries, Anisyah; Tan, Joanne T M; Ravindran, Dhanya; Williams, Helen; Medbury, Heather J; Lindsay, Laura; Hawkins, Clare; Prosser, Hamish C G; Bursill, Christina A.

In: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 31, No. 3, 03.2017, p. 1179-1192.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Ridiandries, A, Tan, JTM, Ravindran, D, Williams, H, Medbury, HJ, Lindsay, L, Hawkins, C, Prosser, HCG & Bursill, CA 2017, 'CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis', FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol. 31, no. 3, pp. 1179-1192. https://doi.org/10.1096/fj.201600540R

APA

Ridiandries, A., Tan, J. T. M., Ravindran, D., Williams, H., Medbury, H. J., Lindsay, L., ... Bursill, C. A. (2017). CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 31(3), 1179-1192. https://doi.org/10.1096/fj.201600540R

Vancouver

Ridiandries A, Tan JTM, Ravindran D, Williams H, Medbury HJ, Lindsay L et al. CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2017 Mar;31(3):1179-1192. https://doi.org/10.1096/fj.201600540R

Author

Ridiandries, Anisyah ; Tan, Joanne T M ; Ravindran, Dhanya ; Williams, Helen ; Medbury, Heather J ; Lindsay, Laura ; Hawkins, Clare ; Prosser, Hamish C G ; Bursill, Christina A. / CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis. In: FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2017 ; Vol. 31, No. 3. pp. 1179-1192.

Bibtex

@article{99743f9f8b964353bf5a2d3f29fba43d,
title = "CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis",
abstract = "Increasing evidence shows that CC-chemokines promote inflammatory-driven angiogenesis, with little to no effect on hypoxia-mediated angiogenesis. Inhibition of the CC-chemokine class may therefore affect angiogenesis differently depending on the pathophysiological context. We compared the effect of CC-chemokine inhibition in inflammatory and physiological conditions. In vitro, the broad-spectrum CC-chemokine inhibitor {"}35K{"} inhibited inflammatory-induced endothelial cell proliferation, migration, and tubulogenesis, with more modest effects in hypoxia. In vivo, adenoviruses were used to overexpress 35K (Ad35K) and GFP (AdGFP, control virus). Plasma chemokine activity was suppressed by Ad35K in both models. In the periarterial femoral cuff model of inflammatory-driven angiogenesis, overexpression of 35K inhibited adventitial neovessel formation compared with control AdGFP-infused mice. In contrast, 35K preserved neovascularization in the hindlimb ischemia model and had no effect on physiological neovascularization in the chick chorioallantoic membrane assay. Mechanistically, 2 key angiogenic proteins (VEGF and hypoxia-inducible factor-1α) were conditionally regulated by 35K, such that expression was inhibited in inflammation but was unchanged in hypoxia. In conclusion, CC-chemokine inhibition by 35K suppresses inflammatory-driven angiogenesis while preserving physiological ischemia-mediated angiogenesis via conditional regulation of VEGF and hypoxia-inducible factor-1α. CC-chemokine inhibition may be an alternative therapeutic strategy for suppressing diseases associated with inflammatory angiogenesis without inducing the side effects caused by global inhibition.- Ridiandries, A., Tan, J. T. M., Ravindran, D., Williams, H., Medbury, H. J., Lindsay, L., Hawkins, C., Prosser, H. C. G., Bursill, C. A. CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis.",
keywords = "Journal Article",
author = "Anisyah Ridiandries and Tan, {Joanne T M} and Dhanya Ravindran and Helen Williams and Medbury, {Heather J} and Laura Lindsay and Clare Hawkins and Prosser, {Hamish C G} and Bursill, {Christina A}",
note = "{\circledC} FASEB.",
year = "2017",
month = "3",
doi = "10.1096/fj.201600540R",
language = "English",
volume = "31",
pages = "1179--1192",
journal = "F A S E B Journal",
issn = "0892-6638",
publisher = "Federation of American Societies for Experimental Biology",
number = "3",

}

RIS

TY - JOUR

T1 - CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis

AU - Ridiandries, Anisyah

AU - Tan, Joanne T M

AU - Ravindran, Dhanya

AU - Williams, Helen

AU - Medbury, Heather J

AU - Lindsay, Laura

AU - Hawkins, Clare

AU - Prosser, Hamish C G

AU - Bursill, Christina A

N1 - © FASEB.

PY - 2017/3

Y1 - 2017/3

N2 - Increasing evidence shows that CC-chemokines promote inflammatory-driven angiogenesis, with little to no effect on hypoxia-mediated angiogenesis. Inhibition of the CC-chemokine class may therefore affect angiogenesis differently depending on the pathophysiological context. We compared the effect of CC-chemokine inhibition in inflammatory and physiological conditions. In vitro, the broad-spectrum CC-chemokine inhibitor "35K" inhibited inflammatory-induced endothelial cell proliferation, migration, and tubulogenesis, with more modest effects in hypoxia. In vivo, adenoviruses were used to overexpress 35K (Ad35K) and GFP (AdGFP, control virus). Plasma chemokine activity was suppressed by Ad35K in both models. In the periarterial femoral cuff model of inflammatory-driven angiogenesis, overexpression of 35K inhibited adventitial neovessel formation compared with control AdGFP-infused mice. In contrast, 35K preserved neovascularization in the hindlimb ischemia model and had no effect on physiological neovascularization in the chick chorioallantoic membrane assay. Mechanistically, 2 key angiogenic proteins (VEGF and hypoxia-inducible factor-1α) were conditionally regulated by 35K, such that expression was inhibited in inflammation but was unchanged in hypoxia. In conclusion, CC-chemokine inhibition by 35K suppresses inflammatory-driven angiogenesis while preserving physiological ischemia-mediated angiogenesis via conditional regulation of VEGF and hypoxia-inducible factor-1α. CC-chemokine inhibition may be an alternative therapeutic strategy for suppressing diseases associated with inflammatory angiogenesis without inducing the side effects caused by global inhibition.- Ridiandries, A., Tan, J. T. M., Ravindran, D., Williams, H., Medbury, H. J., Lindsay, L., Hawkins, C., Prosser, H. C. G., Bursill, C. A. CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis.

AB - Increasing evidence shows that CC-chemokines promote inflammatory-driven angiogenesis, with little to no effect on hypoxia-mediated angiogenesis. Inhibition of the CC-chemokine class may therefore affect angiogenesis differently depending on the pathophysiological context. We compared the effect of CC-chemokine inhibition in inflammatory and physiological conditions. In vitro, the broad-spectrum CC-chemokine inhibitor "35K" inhibited inflammatory-induced endothelial cell proliferation, migration, and tubulogenesis, with more modest effects in hypoxia. In vivo, adenoviruses were used to overexpress 35K (Ad35K) and GFP (AdGFP, control virus). Plasma chemokine activity was suppressed by Ad35K in both models. In the periarterial femoral cuff model of inflammatory-driven angiogenesis, overexpression of 35K inhibited adventitial neovessel formation compared with control AdGFP-infused mice. In contrast, 35K preserved neovascularization in the hindlimb ischemia model and had no effect on physiological neovascularization in the chick chorioallantoic membrane assay. Mechanistically, 2 key angiogenic proteins (VEGF and hypoxia-inducible factor-1α) were conditionally regulated by 35K, such that expression was inhibited in inflammation but was unchanged in hypoxia. In conclusion, CC-chemokine inhibition by 35K suppresses inflammatory-driven angiogenesis while preserving physiological ischemia-mediated angiogenesis via conditional regulation of VEGF and hypoxia-inducible factor-1α. CC-chemokine inhibition may be an alternative therapeutic strategy for suppressing diseases associated with inflammatory angiogenesis without inducing the side effects caused by global inhibition.- Ridiandries, A., Tan, J. T. M., Ravindran, D., Williams, H., Medbury, H. J., Lindsay, L., Hawkins, C., Prosser, H. C. G., Bursill, C. A. CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis.

KW - Journal Article

U2 - 10.1096/fj.201600540R

DO - 10.1096/fj.201600540R

M3 - Journal article

C2 - 27998907

VL - 31

SP - 1179

EP - 1192

JO - F A S E B Journal

JF - F A S E B Journal

SN - 0892-6638

IS - 3

ER -

ID: 174400792